Tue. 27 Feb 2024, 2:30am ET
Benzinga
News
- Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda's Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest
- Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to Help Protect the Most Vulnerable Populations
- Dengue Incidence Continues to Increase and Poses a Growing Threat to Public Health Worldwide